registHER: An observational cohort study of patients with HER2+metastatic breast cancer

被引：0
|
作者：
Yood, Marianne Ulcickas [1 ,2 ]
Kaufman, Peter A. [3 ,4 ]
Mayer, Musa [5 ]
Rugo, Hope [6 ]
Brufsky, Adam [7 ]
Tan-Chiu, Elizabeth [8 ]
Yardley, Denise [9 ]
Paik, Soonmyung [10 ]
Wang, Lisa [11 ]
Birkner, Merrill [11 ]
Brammer, Melissa [11 ]
Tripathy, Debu [12 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] EpiSource, Hamden, CT USA
[3] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[4] Norris Cotton Canc Ctr, Lebanon, NH USA
[5] AdvancedBC Org, New York, NY USA
[6] UCSF, Ctr Comprehens Canc, San Francisco, CA USA
[7] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA USA
[8] Florida Canc Care, Tamarac, FL USA
[9] Sarah Cannon Res Inst, Nashville, TN USA
[10] Natl Surtal Breast & Bowel Project, Pittsburgh, PA USA
[11] Genentech Inc, San Francisco, CA 94080 USA
[12] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
090
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Outcomes of HER2+Metastatic Breast Cancer (MBC) Patients (PTS) Treated With Continuous Inhibition of HER2 Activity: a Single Institution Study
    Fedele, P.
    Orlando, L.
    Marino, A.
    Mazzoni, E.
    Cinefra, M.
    Nacci, A.
    Sponziello, F.
    Calvani, N.
    Schiavone, P.
    Cinieri, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S343 - S344
  • [32] Treatment Patterns and Associated Outcomes Among Patients with HER2+Metastatic Breast Cancer in the United States
    Lam, Clara
    Della Varghese
    Nordstrom, Beth L.
    Murphy, Brian
    Collins, Jenna
    Mehta, Sandhya
    CANCER RESEARCH, 2023, 83 (05)
  • [33] A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+metastatic breast cancer
    LoRusso, Patricia
    Krop, Ian
    Miller, Kathy
    Ma, Cynthia
    Siegel, Barry A.
    Shields, Anthony F.
    Molnar, Istvan
    Wickham, Thomas
    Reynolds, Joseph
    Campbell, Karen
    Hendriks, Bart
    McClure, Ty
    Moyo, Victor
    Munster, Pamela
    CANCER RESEARCH, 2015, 75
  • [34] Real-world outcomes among HER2+metastatic breast cancer patients with brain metastases
    Lindegger, N.
    Ike, C.
    Schwartz, N. R. M.
    Surinach, A.
    Liu, Y.
    Forero-Torres, A.
    DeBusk, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S365 - S366
  • [35] Real-world outcomes among patients with HER2+metastatic breast cancer with brain metastases
    DeBusk, Kendra
    Ike, Chiemeka
    Lindegger, Nicolas
    Schwartz, Naomi
    Surinach, Andy
    Liu, Yutong
    Forero-Torres, Andres
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 657 - 666
  • [36] Impact of Tucatinib on Progression Free Survival in Patients with HER2+Metastatic Breast Cancer and Brain Metastases
    Loibl, Sibylle
    Lin, Nancy
    Murthy, Rashmi K.
    Hurvitz, Sara A.
    Borges, Virginia
    Oliveria, Mafalda
    Oakman, Catherine
    Khan, Sarah
    Lynch, Cynthia
    Westbrook, Kelly
    Doyle, Catherine
    Reinisch, Mattea
    Callenoni, Marco
    Slamon, Dennis
    Hortobagyi, Gabriel
    Winer, Eric
    Ramos, Jorge
    Feng, Wentao
    Bachelot, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 26 - 26
  • [37] Impact of tucatinib on progression free survival in patients with HER2+metastatic breast cancer and brain metastases
    Reinisch, M.
    Bachelot, T.
    Lin, N. U.
    Murthy, R. K.
    Hurvitz, S.
    Borges, V
    Oliveira, M.
    Oakman, C.
    Khan, S.
    Lynch, C.
    Westbrook, K.
    Doyle, C.
    Colleoni, M.
    Slamon, D.
    Hortobagyi, G.
    Winer, E.
    Ramos, J.
    Feng, W.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 242 - 243
  • [38] Trastuzumab and paclitaxel or vinorelbine for HER2+metastatic breast cancer: A retrospective study and analysis of economic cost
    Scola, A.
    Koussis, H.
    Jirillo, A.
    Ghiotto, C.
    Lonardi, S.
    Bortolami, A.
    Monfardini, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Real world treatment patterns and healthcare resource utilization among HER2+metastatic breast cancer patients with and without brain metastases: A retrospective cohort study
    Ike, Chiemeka
    Schwartz, Naomi
    Surinach, Andy
    Liu, Yutong
    DeBusk, Kendra
    Walters, Thomas
    CANCER RESEARCH, 2021, 81 (04)
  • [40] A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients
    Due, Asbjorn
    Berg, Tobias
    Jensen, Maj-Britt
    Yammeni, Sophie
    Volmer, Lone
    Brems-Eskildsen, Anne Sofie
    Andersen, Klaus Kaae
    Rana, Saeeda
    Knoop, Ann
    Kuemler, Iben
    ACTA ONCOLOGICA, 2023, 62 (02) : 126 - 133
12345